Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor

Journal of Immunology

Volumn 160, Issue 9, 1998, Pages 4553-4560

  Quigg, Richard J ^a   Kozono, Yuko ^b   Berthiaume, Dawn ^b   Lim, Alice ^a   Salant, David J ^c   Weinfeld, Andrew ^b   Griffin, Patricia ^b   Kremmer, Elisabeth ^d   Holers, V Michael ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C4B; DECAY ACCELERATING FACTOR; IMMUNOGLOBULIN G;

ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; COMPLEMENT FIXATION; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE FUSION; GLOMERULONEPHRITIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIBODIES; COMPLEMENT INACTIVATOR PROTEINS; HUMANS; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; RECEPTORS, COMPLEMENT; RECOMBINANT FUSION PROTEINS; SHEEP;

EID: 0032080799     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Boyce, N. W., and S. R. Holdsworth. 1985. Anti-glomerular basement membrane antibody-induced experimental glomerulonephritis: evidence for dose-dependent direct antibody and complement-induced, cell-independent injury. J. Immunol. 135:3918.
2. Lefkowith, J. B., T. Nagamatsu, J. Pippin, and G. F. Schreiner. 1991. Role of leukocytes in metabolic and functional derangement of experimental glomerulonephritis. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 261:F213.
3. Schrijver, G., K. J. M. Assmann, M. J. J. T. Bogman, J. C. M. Robbe, R. M. W. de Waal, and R. A. P. Koene. 1988. Antiglomerular basement membrane nephritis in the mouse. Lab. Invest. 59:484.
4. Brady, H. R., M. J. Hebert, T. Takano, A. Papayianni, H. G. Rennke, D. Sandstrom, A. W. Minto, D. J. Salant, and M. C. Carroll. 1995. Acute nephrotoxic serum nephritis in complement "knockout" mice: relative roles of the classical and alternative pathways in neutrophil recruitment and proteinuria. J. Am. Soc. Nephrol. 6:862 (Abstr.).
5. Kalli, K. R., P. Hsu, and D. T. Fearon. 1994. Therapeutic uses of recombinant complement protein inhibitors. Springer Semin. Immunopathol. 15:417.
6. Moore, F. D. 1994. Therapeutic regulation of the complement system in acute injury states. Adv. Immunol. 56:267.
7. Weisman, H. F., T. Bartow, M. K. Leppo, H. C. Marsh Jr., G. R. Carson, M. F. Concino, M. P. Boyle, K. H. Roux, M. L. Weisfeldt, and D. T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146.
8. Liszewski, M. K., T. C. Farries, D. M. Lublin, I. A. Rooney, and J. P. Atkinson. 1996. Control of the complement system. Adv. Immunol. 61:201.
9. Yeh, C. G., H. C. Marsh Jr., G. R. Carson, L. Berman, M. F. Concino, S. M. Scesney, R. E. Kuestner, R. Skibbens, K. A. Donahue, and S. H Ip. 1991. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats. J. Immunol. 146:250.
10. Hill, J., T. F. Lindsay, F. Ortiz, C. G. Yeh, H. B. Hechtman, and F. D. Moore, Jr. 1992. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J. Immunol. 149:1723.
11. Mulligan, M. S., C. G. Yeh, A. R. Rudolph, and P. A. Ward. 1992. Protective effects of soluble CR1 in complement-and neutrophil-mediated tissue injury. J. Immunol. 148:1479.
12. Piddlesden, S. J., M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassmann, and B. P. Morgan. 1994. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:5477.
13. Ryan, U. S. 1995. Complement inhibitory therapeutics. Nat. Med. 1:967.
14. Couser, W. G., R. J. Johnson, B. A. Young, C. G. Yeh, C. A. Toth, and A. R. Rudolph. 1995. The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J. Am. Soc. Nephrol. 5:1888.
15. 2 chimeric complement inhibitor. J. Exp. Med. 174:1451.
16. Pemberton, M., G. Anderson, V. Vetvicka, D. E. Justus, and G. D. Ross. 1993. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J. Immunol. 150:5104.
17. Frei, Y., J. D. Lambris, and B. Stockinger. 1987. Generation of a monoclonal antibody to mouse C5: application in an ELISA assay for detection of anti-C5 antibodies. Mol. Cell. Probes 1:141.
18. Wane, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA 92:8955.
19. 1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93:8563.
20. Molina, H., W. Wong, T. Kinoshita, C. Brenner, S. Foley, and V. M. Holers. 1992. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologs of human CR1. J Exp. Med. 175:121.
21. Molina, H., T. Kinoshita, C. B. Webster, and V. M. Holers. 1994. Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2. J. Immunol. 153-789.
22. Holey, S., B. Li, M. Dehoff, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur. J. Immunol. 23:1381.
23. Kim, Y. U., T. Kinoshita, H. Molina, D. Hourcade, T. Seya, L. M. Wagner, and V. M. Holers. 1995. Mouse complement regulatory protein Crry/p65 utilizes the specific mechanisms of both decay-accelerating factor and membrane cofactor protein. J. Exp. Med. 181:151.
24. Kurtz, C. B., E. O'Toole, S. M. Christensen, and J. H. Weis. 1990. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 144:3581.
25. Molina, H., T. Kinoshita, K. Inoue, J.-C. Carel, and V. M. Holers. 1990. A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J. Immunol. 145: 2974.
26. Kinoshita, T., U. Thyphronitis, G. C. Tsokos, F. D. Finkelman, K. Hong, H. Sakai, and K. Inoue. 1990. Characterization of murine complement receptor type 2 and its immunological cross-reactivity with type 1 receptor. Int. Immunol. 2:651.
27. Li, B., C. Sallee, M. Dehoff, S. Foley, H. Molina, and V. M. Holers. 1993. Mouse Crry/p65: characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151:4295.
28. Wong, W. W., and D. T. Fearon. 1985. p65: a C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor. J. Immunol. 134:4048.
29. Honjo, T., M. Obata, Y. Yamawaki-Kataoka, T. Kataoka, T. Kawakami, N. Takahashi, and Y. Mano. 1979. Cloning and complete nucleotide sequence of mouse immunoglobulin gamma-1 chain gene. Cell 18:559.
30. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B. Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303.
31. Kremmer, E., S. Thierfelder, E. Felber, G. Hoffmann-Fezer, and M. Wasiliu. 1990. Monoclonal antibodies to complement components without the need of their prior purification. II. Antibodies to mouse C3 and C4. Hybridoma 9:309.
32. Lloyd, C. M., A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. Wells, D. J. Salant, and J. C. Gutierrez-Ramos. 1997. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J. Exp. Med. 185:1371.
33. Salant, D. J., and A. V. Cybulsky. 1988. Experimental glomerulonephritis. Methods Enzymol. 162:421.
34. Quigg, R. J., A. Lim, M. Haas, J. J. Alexander, C. He, and M. C. Carroll. 1998. Immune complex glomerulonephritis in C4-and C3-deficient mice. Kidney Int. 53:320.
35. Mayadas, T. N., D. L. Mendrick, H. R. Brady, T. Tang, A. Papayianni, K. J. M. Assmann, D. D. Wagner, R. O. Hynes, and R. S. Cotran. 1996. Acute passive anti-glomerular basement nephritis in P-selectin-deficient mice. Kidney Int. 49:1342.
36. Quigg, R. J., J. J. Alexander, C. F. Lo, A. Lim, C. He, and V. M. Holers. 1997. Characterization of C3-binding proteins on mouse neutrophils and platelets. J. Immunol. 159:2438.
37. Quigg, R. J., D. R. Abramson, A. V. Cyhulsky, J. Badalamenti, A. W. M. Minto, and D. J. Salant. 1989. Studies with antibodies to cultured rat glomerular epithelial cells: subepithelial immune deposit formation after in vivo injection. Am. J. Pathol. 134:1125.
38. Capon, D. J., S. M. Chamow, J. Mordenti, S. A. Marsters, T. Gregory, H. Mitsuya, R. A. Byrn, C. Lucas, F. M. Wurm, J. E. Groopman, S. Broder, and D. H. Smith. 1989. Designing CD4 immunoadhesins for AIDS therapy. Science 337:525.
39. Kurschner, C., L. Ozmen, G. Garotta, and Z. Dembic. 1992. IFN-γ receptor-Ig fusion proteins: half-life, immunogenicity and in vivo activity. J. Immunol. 149: 4096.
40. Paul, M. S., M. Aegerter, K. Cepek, M. D. Miller, and J. H. Weis. 1990. The murine complement receptor gene family. III. The genomic and transcriptional complexity of the Crry and Crry-ps genes. J. Immunol. 144:1988.
41. Linsley, P. S., P. M. Wallace, J. Johnson, M. G. Gibson, J. L. Greene, J. A. Ledbetter, C. Singh, and M. A. Tepper. 1992. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation marker. Science 257:792.
42. Tang, W. W., L. Feng, J. L. Vannice, and C. B. Wilson. 1994. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J. Clin. Invest. 93:273.
43. Mullisan, M. S., K. J. Johnson, R. F. Todd III, T. B. Issekutz, M. Miyasaka, T. Tamatani, C. W. Smith, D. C. Anderson, and P. A. Ward. 1993. Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J. Clin. Invest. 91: 577.
44. Wu, X., J. Pippin, and J. B. Lefkowith. 1993. Attenuation of immune-mediated glomerulonephritis with an anti-CD11b monoclonal antibody. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 264:F715.
45. Wu, X., A. J. Wittwer, L. S. Carr, B. A. Crippes, J. E. DeLarco, and J. B. Lefkowith. 1994. Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in rat. J. Clin. Invest. 94:337.
46. Feng, L., Y. Xia, T. Yoshimura, and C. B. Wilson. 1995. Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP) antibody. J. Clin. Invest. 95:1017.
47. Wu, X., M. H. Helfrich, M. A. Horton, L. P. Feigen, and J. B. Lefkowith. 1994. Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J. Clin. Invest. 94:928.
48. 1 integrin on rat glomerular epithelial cells. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 262:F1083.
49. Wilson, C. B. 1996. Renal response to immunologic glomerular injury. In The Kidney, B. M. Brenner, ed. W. B. Saunders, Philadelphia, p. 1253.
50. Wang, Y., S. A. Rollins, J. A. Madri, and L. A. Matis. 1995. Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc. Natl. Acad. Sci. USA 92:8955.